Fibroblast growth factor 20 attenuates pathological cardiac hypertrophy by activating the SIRT1 signaling pathway

Abstract excerpt

Cardiac hypertrophy occurs initially in response to an increased cardiac load as a compensatory mechanism to maintain cardiac output. However, sustained pathological hypertrophy can develop into heart failure and cause sudden death. Fibroblast growth factor 20 (FGF20) is a member of the fibroblast growth factor family, which involved in apoptosis, aging, inflammation, and autophagy. The precise function of FGF20...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cardiovascular Disease and Adiposity
• Share to Fibroblast Growth Factor Research
• Share to Sirtuins and Resveratrol in Medicine